Takara Bio Inc.
OTC: TKBIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tsuyoshi Miyamura
- Employees
- 1,838
- Headquarters
- Kusatsu, Japan
- IPO year
- 2020
- Market cap
- $879.0M
- Website
- https://www.takara-bio.com
Loading TKBIF…
Loading profile data…Frequently asked questions about TKBIF
What does Takara Bio Inc. (TKBIF) do?
Takara Bio Inc., a subsidiary of Takara Holdings Inc., is a Japan-based biotechnology firm established in Kusatsu in 2002. The company operates globally, with a presence in Japan, China, other Asian countries, the United States, and Europe, focusing on three primary areas: general biotechnology, contract development and manufacturing (CDMO) serv...
Where does TKBIF trade?
Takara Bio Inc. (TKBIF) trades on the Other OTC.
What sector is TKBIF in?
Takara Bio Inc. (TKBIF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Takara Bio Inc.?
Tsuyoshi Miyamura is the chief executive officer of Takara Bio Inc. (TKBIF).
Where is Takara Bio Inc. headquartered?
Takara Bio Inc. is headquartered in Japan.
Does TKBIF pay a dividend?
Yes — Takara Bio Inc. (TKBIF) paid a trailing twelve-month dividend of USD 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TKBIF go public?
Takara Bio Inc. (TKBIF) completed its initial public offering in 2020.